TABLE 1.
Baseline and clinical characteristics of the T2DM subgroups
| Variables | Control patients | CAD patients | p value |
|---|---|---|---|
| Number | 50 | 45 | – |
| Sex (male/female) | 28/22 | 30/15 | 0.833 |
| Age (years) | 55.3 ± 14.4 | 60.0 ± 9.4 | 0.063 |
| BMI (kg/m2) | 26.11 ± 4.42 | 27.39 ± 3.60 | 0.128 |
| Systolic BP (mmHg) | 145.56 ± 20.53 | 140.36 ± 16.90 | 0.183 |
| Diastolic BP (mmHg) | 87.66 ± 10.33 | 84.44 ± 10.20 | 0.131 |
| Total cholesterol (mmol/L) | 4.58 ± 1.24 | 4.29 ± 1.21 | 0.251 |
| Triglyceride (mmol/L) | 1.60 ± 1.12 | 1.88 ± 2.08 | 0.431 |
| HDL cholesterol (mmol/L) | 1.08 ± 0.29 | 1.09 ± 0.25 | 0.985 |
| LDL cholesterol (mmol/L) | 2.67 ± 0.99 | 2.50 ± 0.97 | 0.399 |
| Glucose (mmol/L) | 8.91 ± 2.84 | 8.01 ± 2.63 | 0.115 |
| HbA1c (%) | 8.98 ± 1.84 | 8.40 ± 1.61 | 0.111 |
| Creatinine (μmol/L) | 72.39 ± 29.94 | 71.32 ± 20.63 | 0.842 |
| Smoking (n, %) | 20 (40%) | 25 (55.6%) | 0.153 |
Note: Values are mean ± SD.